Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Clinical Nutrition Market to Reach $65.73 Billion by 2027 at a CAGR of 6.65%

DUBLIN, Sept. 27, 2022 /PRNewswire/ -- The "Clinical Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

The global clinical nutrition market size reached US$ 44.67 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 65.73 Billion by 2027, exhibiting a CAGR of 6.65% during 2021-2027. 

Clinical nutrition refers to a specialized field of nutrition science that focuses on disease management by adopting medical nutrition therapies. It also includes the diagnosis and prevention of nutritional and metabolic conditions associated with chronic disorders that occur due to the lack of essential nutrients.

Some of the commonly available types of clinical nutrition include infant nutrition, enteral nutrition, and parenteral nutrition. Clinical nutrition offers numerous benefits in reducing the consequences of malnutrition, enhancing the response to disease treatment, boosting immunity levels, enhancing ingestion abilities, etc.

Clinical Nutrition Market Trends:

The rising prevalence of metabolic disorders that increase the risk of obesity, high blood pressure, abnormal cholesterol levels, etc., is primarily driving the global clinical nutrition market. Moreover, the expanding geriatric population, who are more prone to chronic gastrointestinal ailments, is also propelling the demand for clinical nutrition in the home healthcare model.

Besides this, elevating number of preterm births coupled with the inflating need for clinical nutrition in the pediatric medicine segment is further augmenting the market growth. Additionally, continuous upgradation of healthcare infrastructures and the introduction of government awareness programs regarding the easy accessibility to clinical nutrition procedures for disease management are acting as significant growth-inducing factors.

Apart from this, in the COVID-19 pandemic, the demand for immunity-boosting alternatives, including clinical nutrition, has significantly increased to prevent the risk of coronavirus infection. The infection results in severe lack of appetite, anosmia dysgeusia, diarrhea, etc., which can lead to disease-related malnutrition. Clinical nutrition aid in treating acute malnutrition and protein deficiency along with improving immune defenses in COVID-19 patients. Moreover, significant innovations in clinical nutrition solutions, including lipid emulsions optimization, and the introduction of oral clinical nutrition formula in liquid form, are expected to drive the global clinical nutrition market over the forecasted period.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global clinical nutrition market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, route of administration, application and end user.

Breakup by Product:

Breakup by Route of Administration:

Breakup by Application:

Breakup by End User:

Breakup by Region:

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Clinical Nutrition Market

6 Market Breakup by Product

7 Market Breakup by Route of Administration

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/jilxxd

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

These press releases may also interest you

at 07:35
AVROBIO, Inc. , a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced new interim pharmacokinetic, pharmacodynamic and clinical efficacy data, showing stabilization or reversal of...

at 07:30
VitalHub Corp. (the "Company" or "VitalHub") is pleased to announce a multi-year licensing contract of subsidiary Transforming System's SHREWD Platform and SHREWD Resilience offerings to Coventry and Warwickshire Integrated Care Board ("ICB")...

at 07:30
Cronos Group Inc. ("Cronos"), an innovative global cannabinoid company, today announced the launch of a CBC-focused product, the Spinach FEELZtm THC+CBC Day Trip Mango Lime gummies, utilizing Ginkgo Bioworks' platform for organism design and...

at 07:30
CareRx Corporation ("CareRx" or the "Company") , Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that Dr. Jack Shevel, a director and Chairman Emeritus of CareRx, will retire...

at 07:30
Pixelgen Technologies emerged from stealth today with a mission to bring a new dimension to single-cell spatial proteomics. The launch follows the close of an approximate $6 million seed round, led by Navigare Ventures, which will support the...

at 07:30
Tris Pharma, Inc. ("Tris"), a fully integrated, innovation-driven CNS company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), and a pipeline of treatments for pain, addiction,...

News published on 27 september 2022 at 15:30 and distributed by: